Ninth Circuit Reverses Judgment for Pharmaceutical Company

April 4, 2014

The Ninth Circuit has reversed a judgment against Martin’s client in a products liability case for injuries caused by the prescription drug Zometa, manufactured by Novartis Pharmaceuticals Corporation. ┬áIn a published opinion, the Ninth Circuit found that the lower court had abused its discretion by excluding the testimony of the plaintiff’s causation expert.